Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00601172

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Nausea and Vomiting, Chemotherapy-Induced Clinical Trial

Official title:
A Study of Single Dose Intravenous Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Oxaliplatin Induced Nausea and Vomiting.

Clinical Trial Summary

This a Phase III trial designed to determine if IV casopitant plus dexamethasone and ondansetron is more effective in the prevention of vomiting and nausea then dexamethasone and ondansetrone alone following the administration of moderately emetogenic oxaliplatin-based chemotherapy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00601172
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 3
Start date March 10, 2008
Completion date April 13, 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT00404378 - Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769] Phase 1
Completed NCT00431236 - A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy Phase 3
Completed NCT00405080 - A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant). Phase 1
Completed NCT00404274 - A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers Phase 1
Completed NCT00440128 - The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer Phase 1
Completed NCT00511823 - The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects Phase 1
Completed NCT00366834 - Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting Phase 3
Completed NCT00437229 - A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults Phase 1
Completed NCT00104403 - Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy Phase 2
Completed NCT01449188 - To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects Phase 1
Terminated NCT00334646 - Cyclophosphamide Drug Interaction Study In Cancer Patients Phase 1
Completed NCT00460707 - A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults Phase 1